Clinical Trials Browser

Withdrawn × ficlatuzumab × Clear all

NCT04100330 2020-03-31

CyFi2

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01189513 2012-02-20

SCH-900105 in Recurrent Glioblastoma

Phase 1 Withdrawn

Glioblastoma, Gliosarcoma